Literature DB >> 9768818

The role of iron in doxorubicin-induced cardiomyopathy.

C Myers1.   

Abstract

Doxorubicin participates in a wide range of free radical reactions. The drug can undergo one electron reduction to the corresponding semiquinone, leading the generation of superoxide and hydrogen peroxide. Additionally, the drug causes the disappearance of cardiac glutathione peroxidase, leaving the heart with no means of disposing of the hydrogen peroxide thus generated. Doxorubicin also is a powerful iron chelator and the resultant iron-drug complex is an efficient catalyst of the conversion of hydrogen peroxide to the highly reactive hydroxyl radical. Without the drug-iron complex, little or no cardiac production of hydroxyl radical occurs and heart damage does not occur.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768818

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  41 in total

Review 1.  Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure.

Authors:  Stuart D Katz; Haoyi Zheng
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

Review 2.  Biomarker Discovery in Cardio-Oncology.

Authors:  Anita Vohra; Aarti Asnani
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

Review 3.  Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration.

Authors:  Jessie Wettig Yester; Bernhard Kühn
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

4.  An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL.

Authors:  Yun Mai; J Jessica Yu; Boris Bartholdy; Zijun Y Xu-Monette; Esther E Knapp; Fei Yuan; Hongshan Chen; B Belinda Ding; Zhihua Yao; Bhaskar Das; Yiyu Zou; Ken He Young; Samir Parekh; B Hilda Ye
Journal:  Blood       Date:  2016-10-13       Impact factor: 22.113

Review 5.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

Review 6.  Doxorubicin-induced apoptosis: implications in cardiotoxicity.

Authors:  B Kalyanaraman; Joy Joseph; Shashi Kalivendi; Suwei Wang; Eugene Konorev; Srigiridhar Kotamraju
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 7.  Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.

Authors:  Sakshi Jasra; Jesus Anampa
Journal:  Curr Treat Options Oncol       Date:  2018-05-11

8.  Beet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells.

Authors:  Sayantanee Das; Scott M Filippone; Denise S Williams; Anindita Das; Rakesh C Kukreja
Journal:  Mol Cell Biochem       Date:  2016-08-26       Impact factor: 3.396

9.  Scavenging effects of dexrazoxane on free radicals.

Authors:  Zhang Junjing; Zhao Yan; Zhao Baolu
Journal:  J Clin Biochem Nutr       Date:  2010-10-29       Impact factor: 3.114

10.  Attenuation effect of Abnormal Savda Munziq on liver and heart toxicity caused by chemotherapy in mice.

Authors:  Ainiwaer Aikemu; Nurmuhamat Amat; Abdiryim Yusup; Lianlian Shan; Xinwei Qi; Halmurat Upur
Journal:  Exp Ther Med       Date:  2016-05-10       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.